Novel therapy of hyperhomocysteinemia in mild cognitive impairment, Alzheimer’s disease, and other dementing disorders

[1]  J. Schneider,et al.  24-Hour Rhythms of DNA Methylation and Their Relation with Rhythms of RNA Expression in the Human Dorsolateral Prefrontal Cortex , 2014, PLoS genetics.

[2]  A. Hake,et al.  Clinical Interventions in Aging Dovepress Ann M Hake 4,5 , 2022 .

[3]  Minhai Jiang,et al.  Hyperhomocysteinemia and Risk of Cognitive Decline: A Meta-Analysis of Prospective Cohort Studies , 2014, European Neurology.

[4]  T. Joska,et al.  Regulated DNA Methylation and the Circadian Clock: Implications in Cancer , 2014, Biology.

[5]  I. Kruman,et al.  Impaired one carbon metabolism and DNA methylation in alcohol toxicity , 2014, Journal of neurochemistry.

[6]  T. Shea,et al.  Lifetime requirement of the methionine cycle for neuronal development and maintenance , 2014, Current opinion in psychiatry.

[7]  P. van’t Veer,et al.  Interactions between plasma concentrations of folate and markers of vitamin B12 status with cognitive performance in elderly people not exposed to folic acid fortification: the Hordaland Health Study , 2013, British Journal of Nutrition.

[8]  A. Paetau,et al.  Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. , 2013, Brain : a journal of neurology.

[9]  U. Vogel,et al.  Aberrant DNA methylation of miR‐219 promoter in long‐term night shiftworkers , 2013, Environmental and molecular mutagenesis.

[10]  G. Hankey,et al.  Homocysteine, frailty, and all-cause mortality in older men: the health in men study. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  J. Guiramand,et al.  N-acetyl-cysteine prevents pyramidal cell disarray and reelin-immunoreactive neuron deficiency in CA3 after prenatal immune challenge in rats , 2013, Pediatric Research.

[12]  P. Sassone-Corsi.  When Metabolism and Epigenetics Converge , 2013, Science.

[13]  H. Beck,et al.  Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons , 2013, Experimental Brain Research.

[14]  Simone Reppermund,et al.  Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing study. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[15]  C. Myers,et al.  The Relationship between Associative Learning, Transfer Generalization, and Homocysteine Levels in Mild Cognitive Impairment , 2012, PloS one.

[16]  R. Leak,et al.  Rescue from a two hit, high-throughput model of neurodegeneration with N-acetyl cysteine , 2012, Neurochemistry International.

[17]  G. Kemmler,et al.  Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort , 2012, The journal of nutrition, health & aging.

[18]  A. Smith,et al.  Cognitive and clinical outcomes of homocysteine‐lowering B‐vitamin treatment in mild cognitive impairment: a randomized controlled trial , 2012, International journal of geriatric psychiatry.

[19]  T. Ekström,et al.  Epigenetic regulation in obesity , 2012, International Journal of Obesity.

[20]  L. Greene-Finestone,et al.  Vitamin B-12 and homocysteine status in a folate-replete population: results from the Canadian Health Measures Survey. , 2011, The American journal of clinical nutrition.

[21]  D. Butterfield,et al.  Proteomic analysis of brain proteins in APP/PS‐1 human double mutant knock‐in mice with increasing amyloid β‐peptide deposition: Insights into the effects of in vivo treatment with N‐acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease , 2011, Proteomics.

[22]  H. Beck,et al.  N-acetyl Cysteine Treatment Rescues Cognitive Deficits Induced by Mitochondrial Dysfunction in G72/G30 Transgenic Mice , 2011, Neuropsychopharmacology.

[23]  Jenny Lee,et al.  A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. , 2011, Clinical nutrition.

[24]  F. Cagampang,et al.  Epigenetic priming of the metabolic syndrome , 2011, Toxicology mechanisms and methods.

[25]  D. Galasko,et al.  Comparison of the Memory Performance Index With Standard Neuropsychological Measures of Cognition , 2011, American journal of Alzheimer's disease and other dementias.

[26]  J. Ordovás,et al.  Epigenetics and cardiovascular disease , 2010, Nature Reviews Cardiology.

[27]  L. Allen,et al.  Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. , 2009, The American journal of clinical nutrition.

[28]  S. Sedimbi,et al.  Diabetes--role of epigenetics, genetics, and physiological factors. , 2009, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[29]  W. Shankle,et al.  Development and validation of the Memory Performance Index: Reducing measurement error in recall tests , 2009, Alzheimer's & Dementia.

[30]  T. Gómez-Isla,et al.  Homocysteine and Cognitive Impairment , 2008, Dementia and Geriatric Cognitive Disorders.

[31]  C. Estrada,et al.  Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2‐dependent cyclin E expression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Ramon Diaz-Arrastia,et al.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. , 2008, JAMA.

[33]  Jan-Gowth Chang,et al.  A pilot study for circadian gene disturbance in dementia patients , 2008, Neuroscience Letters.

[34]  C. Dufouil,et al.  Homocysteine, Folate and Cognition in a Large Community-Based Sample of Elderly People – The 3C Dijon Study , 2008, Neuroepidemiology.

[35]  F. D’Anselmi,et al.  B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.

[36]  D. Jacobsen,et al.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. , 2007, Antioxidants & redox signaling.

[37]  W. Riesen,et al.  Economic Impact of Hyperhomocysteinemia in Switzerland , 2005, Cardiovascular Drugs and Therapy.

[38]  S. Singh,et al.  Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture , 2005, Brain Research.

[39]  William R. Shankle,et al.  Methods to improve the detection of mild cognitive impairment. , 2005 .

[40]  M. Siebler,et al.  Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity , 2004, Journal of the Neurological Sciences.

[41]  B. Reisberg,et al.  Dementia: a systematic approach to identifying reversible causes. , 1986, Geriatrics.

[42]  P. Wilson,et al.  Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. , 2000, Public health reviews.